The Incidence and Influencing Factors of In-hospital Frailty Progression following Transcatheter Aortic Valve Implantation.

IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI:10.2169/internalmedicine.3146-23
Tatsuya Miyazaki, Akihito Tanaka, Yoshiyuki Tokuda, Yoshinori Shirai, Koji Mizutani, Kenji Furusawa, Sho Akita, Takahiro Ozeki, Kiyonori Kobayashi, Hideki Ishii, Masato Mutsuga, Toyoaki Murohara
{"title":"The Incidence and Influencing Factors of In-hospital Frailty Progression following Transcatheter Aortic Valve Implantation.","authors":"Tatsuya Miyazaki, Akihito Tanaka, Yoshiyuki Tokuda, Yoshinori Shirai, Koji Mizutani, Kenji Furusawa, Sho Akita, Takahiro Ozeki, Kiyonori Kobayashi, Hideki Ishii, Masato Mutsuga, Toyoaki Murohara","doi":"10.2169/internalmedicine.3146-23","DOIUrl":null,"url":null,"abstract":"<p><p>Objective Patients undergoing transcatheter aortic valve implantation (TAVI) are generally older and frailty is therefore an important clinical issue. The baseline degree of frailty is associated with the prognosis in patients undergoing TAVI; however, the incidence of in-hospital frailty progression and its influencing factors have not yet been elucidated. Methods This observational, single-center study retrospectively evaluated 281 patients who underwent TAVI. The degree of frailty at baseline and discharge was evaluated using the Clinical Frailty Scale (CFS). In-hospital frailty progression was defined as an increase of at least one level in the CFS score at discharge from baseline, and predictors of frailty progression were assessed. Results The median baseline CFS score was 4.0 (interquartile range: 3.0-4.0). In-hospital frailty progression was observed in 49 patients (17.4%). No significant differences were observed in age, sex, comorbidities, or surgical risk scores between patients with and without frailty progression. Patients with frailty progression experienced stroke more frequently during hospitalization than those without (12.2% vs. 1.3%, p=0.001). A multivariable logistic analysis showed that in-hospital stroke was a significant predictor of frailty progression (odds ratio, 10.7; 95% confidence interval: 2.34-49.2, p=0.002). Patients with frailty progression had a longer hospital stay than those without frailty progression [7.0 (4.0-17.0) vs. 4.0 (4.0-8.0) days, p=0.001]. Conclusion In-hospital frailty progression was not uncommon in patients undergoing TAVI. Stroke incidence was a significant influencing factor in frailty progression, whereas baseline comorbidities and surgical risks were not.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"3283-3289"},"PeriodicalIF":1.0000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2169/internalmedicine.3146-23","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective Patients undergoing transcatheter aortic valve implantation (TAVI) are generally older and frailty is therefore an important clinical issue. The baseline degree of frailty is associated with the prognosis in patients undergoing TAVI; however, the incidence of in-hospital frailty progression and its influencing factors have not yet been elucidated. Methods This observational, single-center study retrospectively evaluated 281 patients who underwent TAVI. The degree of frailty at baseline and discharge was evaluated using the Clinical Frailty Scale (CFS). In-hospital frailty progression was defined as an increase of at least one level in the CFS score at discharge from baseline, and predictors of frailty progression were assessed. Results The median baseline CFS score was 4.0 (interquartile range: 3.0-4.0). In-hospital frailty progression was observed in 49 patients (17.4%). No significant differences were observed in age, sex, comorbidities, or surgical risk scores between patients with and without frailty progression. Patients with frailty progression experienced stroke more frequently during hospitalization than those without (12.2% vs. 1.3%, p=0.001). A multivariable logistic analysis showed that in-hospital stroke was a significant predictor of frailty progression (odds ratio, 10.7; 95% confidence interval: 2.34-49.2, p=0.002). Patients with frailty progression had a longer hospital stay than those without frailty progression [7.0 (4.0-17.0) vs. 4.0 (4.0-8.0) days, p=0.001]. Conclusion In-hospital frailty progression was not uncommon in patients undergoing TAVI. Stroke incidence was a significant influencing factor in frailty progression, whereas baseline comorbidities and surgical risks were not.

经导管主动脉瓣植入术后院内虚弱进展的发生率和影响因素。
目的 接受经导管主动脉瓣植入术(TAVI)的患者一般年龄较大,因此虚弱是一个重要的临床问题。基线虚弱程度与接受 TAVI 患者的预后有关;然而,院内虚弱进展的发生率及其影响因素尚未阐明。方法 该观察性单中心研究回顾性评估了 281 名接受 TAVI 的患者。采用临床虚弱量表(CFS)评估基线和出院时的虚弱程度。院内虚弱进展的定义是出院时 CFS 评分比基线至少增加一级,并对虚弱进展的预测因素进行了评估。结果 CFS 评分基线中位数为 4.0(四分位间范围:3.0-4.0)。49名患者(17.4%)出现院内虚弱进展。体弱进展患者与未体弱进展患者在年龄、性别、合并症或手术风险评分方面无明显差异。与未发生中风的患者相比,体弱进展患者在住院期间发生中风的频率更高(12.2% 对 1.3%,P = 0.001)。多变量逻辑分析显示,院内中风是虚弱进展的一个重要预测因素(几率比 10.7;95% 置信区间:2.34-49.2,p = 0.002)。与无虚弱进展的患者相比,虚弱进展的患者住院时间更长[7.0 (4.0-17.0) 天 vs. 4.0 (4.0-8.0) 天,p = 0.001]。结论 在接受 TAVI 的患者中,院内体弱进展并不少见。卒中发生率是导致虚弱进展的重要影响因素,而基线合并症和手术风险则不是。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Internal Medicine
Internal Medicine 医学-医学:内科
CiteScore
1.90
自引率
8.30%
发文量
0
审稿时长
2.2 months
期刊介绍: Internal Medicine is an open-access online only journal published monthly by the Japanese Society of Internal Medicine. Articles must be prepared in accordance with "The Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see Annals of Internal Medicine 108: 258-265, 1988), must be contributed solely to the Internal Medicine, and become the property of the Japanese Society of Internal Medicine. Statements contained therein are the responsibility of the author(s). The Society reserves copyright and renewal on all published material and such material may not be reproduced in any form without the written permission of the Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信